357 related articles for article (PubMed ID: 29148890)
1. Changes in the Use of Long-Acting Reversible Contraceptive Methods Among U.S. Nulliparous Women: Results from the 2006-2010, 2011-2013, and 2013-2015 National Survey of Family Growth.
Ihongbe TO; Masho SW
J Womens Health (Larchmt); 2018 Mar; 27(3):245-252. PubMed ID: 29148890
[TBL] [Abstract][Full Text] [Related]
2. Long-acting reversible contraceptive use in the post-abortion period among women seeking abortion in mainland China: intentions and barriers.
Luo Z; Gao L; Anguzu R; Zhao J
Reprod Health; 2018 May; 15(1):85. PubMed ID: 29793501
[TBL] [Abstract][Full Text] [Related]
3. Postabortion Initiation of Long-Acting Reversible Contraception by Adolescent and Nulliparous Women in New Zealand.
Rose SB; Garrett SM
J Adolesc Health; 2016 Feb; 58(2):160-6. PubMed ID: 26603946
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population.
Law A; Pilon D; Lynen R; Laliberté F; Gozalo L; Lefebvre P; Duh MS
Reprod Health; 2016 Aug; 13(1):96. PubMed ID: 27549429
[TBL] [Abstract][Full Text] [Related]
5. Long-Acting Reversible Contraception Counseling and Use for Older Adolescents and Nulliparous Women.
Gibbs SE; Rocca CH; Bednarek P; Thompson KMJ; Darney PD; Harper CC
J Adolesc Health; 2016 Dec; 59(6):703-709. PubMed ID: 27665153
[TBL] [Abstract][Full Text] [Related]
6. Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder.
Matusiewicz AK; Melbostad HS; Heil SH
Contraception; 2017 Nov; 96(5):365-369. PubMed ID: 28778423
[TBL] [Abstract][Full Text] [Related]
7. Changes in Use of Long-Acting Reversible Contraceptive Methods Among U.S. Women, 2009-2012.
Kavanaugh ML; Jerman J; Finer LB
Obstet Gynecol; 2015 Nov; 126(5):917-927. PubMed ID: 26444110
[TBL] [Abstract][Full Text] [Related]
8. Magnitude and factors for method discontinuation and switching among long acting reversible contraceptive users in health facilities of Southern Ethiopia.
Bereku T; Habtu Y; Abreham B; Ayele M; Eliso M
Reprod Health; 2022 Feb; 19(1):47. PubMed ID: 35183214
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with postpartum use of long-acting reversible contraception.
Oduyebo T; Zapata LB; Boutot ME; Tepper NK; Curtis KM; D'Angelo DV; Marchbanks PA; Whiteman MK
Am J Obstet Gynecol; 2019 Jul; 221(1):43.e1-43.e11. PubMed ID: 30885772
[TBL] [Abstract][Full Text] [Related]
10. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
Chiles DP; Roberts TA; Klein DA
Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
[TBL] [Abstract][Full Text] [Related]
11. Contraceptive use in Latin America and the Caribbean with a focus on long-acting reversible contraceptives: prevalence and inequalities in 23 countries.
Ponce de Leon RG; Ewerling F; Serruya SJ; Silveira MF; Sanhueza A; Moazzam A; Becerra-Posada F; Coll CVN; Hellwig F; Victora CG; Barros AJD
Lancet Glob Health; 2019 Feb; 7(2):e227-e235. PubMed ID: 30683240
[TBL] [Abstract][Full Text] [Related]
12. Trends in long-acting reversible contraception use among U.S. women aged 15-44.
Branum AM; Jones J
NCHS Data Brief; 2015 Feb; (188):1-8. PubMed ID: 25714042
[TBL] [Abstract][Full Text] [Related]
13. Trends and determinants of use of long-acting reversible contraception use among young women in France: results from three national surveys conducted between 2000 and 2010.
Moreau C; Bohet A; Hassoun D; Teboul M; Bajos N;
Fertil Steril; 2013 Aug; 100(2):451-8. PubMed ID: 23663994
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of women in the United States who use long-acting reversible contraceptive methods.
Kavanaugh ML; Jerman J; Hubacher D; Kost K; Finer LB
Obstet Gynecol; 2011 Jun; 117(6):1349-1357. PubMed ID: 21606745
[TBL] [Abstract][Full Text] [Related]
15. Contraceptive method mix and preference: A focus on long acting reversible contraception in Urban Cameroon.
Ajong AB; Njotang PN; Kenfack B; Essi MJ; Yakum MN; Iballa FBS; Mbu ER
PLoS One; 2018; 13(8):e0202967. PubMed ID: 30138474
[TBL] [Abstract][Full Text] [Related]
16. Increasing uptake of long-acting reversible contraception with structured contraceptive counselling: cluster randomised controlled trial (the LOWE trial).
Emtell Iwarsson K; Envall N; Bizjak I; Bring J; Kopp Kallner H; Gemzell-Danielsson K
BJOG; 2021 Aug; 128(9):1546-1554. PubMed ID: 33988917
[TBL] [Abstract][Full Text] [Related]
17. Differences in Contraceptive Discontinuation Among Black and White Women: Evidence from the Contraceptive CHOICE Project.
Allsworth JE; Secura GM; Ajibade OO; Peipert JF
J Womens Health (Larchmt); 2018 May; 27(5):599-606. PubMed ID: 29768114
[TBL] [Abstract][Full Text] [Related]
18. Familiarity with Long-acting Reversible Contraceptives among Obstetrics and Gynecology, Family Medicine, and Pediatrics Residents: Results of a 2015 National Survey and Implications for Contraceptive Provision for Adolescents.
Davis SA; Braykov NP; Lathrop E; Haddad LB
J Pediatr Adolesc Gynecol; 2018 Feb; 31(1):40-44. PubMed ID: 28942106
[TBL] [Abstract][Full Text] [Related]
19. Facilitators and Barriers to Implementation of Long-Acting Reversible Contraceptive Services for Adolescent Girls and Young Women in Gaborone, Botswana.
Henry D; Wood S; Moshashane N; Ramontshonyana K; Amutah C; Maleki P; Howlett C; Brooks MJ; Mussa A; Joel D; Steenhoff AP; Akers AY; Morroni C
J Pediatr Adolesc Gynecol; 2021 Aug; 34(4):504-513. PubMed ID: 33766793
[TBL] [Abstract][Full Text] [Related]
20. The Tupange Project in Kenya: A Multifaceted Approach to Increasing Use of Long-Acting Reversible Contraceptives.
Muthamia M; Owino K; Nyachae P; Kilonzo M; Kamau M; Otai J; Kabue M; Keyonzo N
Glob Health Sci Pract; 2016 Aug; 4 Suppl 2(Suppl 2):S44-59. PubMed ID: 27540124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
